4.8 Article

Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells

期刊

NATURE BIOTECHNOLOGY
卷 27, 期 11, 页码 1033-U100

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.1580

关键词

-

资金

  1. National Institutes of Health (NIH)
  2. Burroughs Wellcome Fund
  3. Leukemia and Lymphoma Society
  4. Harvard Stem Cell Institute
  5. Agency of Science, Technology and Research International Fellowship
  6. Institute of Medical Biology, Singapore
  7. Canadian Institutes of Health Research
  8. Breast Cancer Research Foundation, NY
  9. Department of Defense
  10. Congressionally Directed Medical Research Programs (CDMRPs)
  11. Breast Cancer Research Program (BCRP)

向作者/读者索取更多资源

Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells by enforced expression of transcription factors. Using serial live imaging of human fibroblasts undergoing reprogramming, we identified distinct colony types that morphologically resemble embryonic stem (ES) cells yet differ in molecular phenotype and differentiation potential. By analyzing expression of pluripotency markers, methylation at the OCT4 and NANOG promoters and differentiation into teratomas, we determined that only one colony type represents true iPS cells, whereas the others represent reprogramming intermediates. Proviral silencing and expression of TRA-1-60, DNMT3B and REX1 can be used to distinguish the fully reprogrammed state, whereas alkaline phosphatase, SSEA-4, GDF3, hTERT and NANOG are insufficient as markers. We also show that reprogramming using chemically defined medium favors formation of fully reprogrammed over partially reprogrammed colonies. Our data define molecular markers of the fully reprogrammed state and highlight the need for rigorous characterization and standardization of putative iPS cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据